Company profile
Encision Inc.
OTC: ECIA · Healthcare · Medical - Instruments & Supplies
#679 of 1,418 Healthcare companies by revenue40th-percentile growth
EA Score
——FH —DQ 55GM —SS 52
v0.1 · 25/100 weight · pillars only
↑ growth stability, disclosure history · ↓ filing timeliness, 3-yr revenue growth
Methodology →Revenue TTM
$6.3M
Rev growth YoY (TTM)
-3.0%
Net income (FY)
-$220.2k
Employees
23
as of 2026-08-29
Market cap
$2.4M
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.6M$6.6M2025
Net income-$220.2k-$220.2k2025
Operating income-$172.0k-$172.0k2025
Total assets$3.7M$3.7M2025
Liabilities$2.0M$2.0M2025
Equity$1.7M$1.7M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product95%
Service5%
By geography
AUSTRALIA87%
NEW ZEALAND13%
The read
What is Encision Inc.’s revenue?
Encision Inc. booked $6.6M in FY2025 revenue, contracting 0.5% year over year — about the middle of the pack among Healthcare companies we track, at a -3.4% net margin.
Peers · Healthcare
Pacific Health Care Organization, Inc.74BFate Therapeutics, Inc.43DEvommune, Inc.45DGlobeImmune, Inc.——Kyntra Bio, Inc.60CViveve Medical, Inc.——Neighbors
Boulder →Key facts
CEORobert H. Fries
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBoulder, CO
ExchangeOTC: ECIA
Employees23
IPO date2004-01-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.